In most of these studies, a bladder carcinogen N-butyl-N-4-hydroxybutyl nitrosamine (BBN), which reliably induces bladder tumors, especially in male rodents, has been used along with androgen/anti-androgen treatment and/or AR knockdown. Here, AR is linked to urinary bladder neoplasm.